Lifecore Biomedical (LCBM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lifecore Biomedical (LCBM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mr. Happy who wrote (25)	10/23/1999 8:05:00 AM
From: Mike	of 43

Earnings were released and wondering if anyone was able to get detailed info? The earnings met expectations and wondering if in the numbers things are positive or negative. First the HA business was up over 120% vs same qtr ly. It was noted that the increase was due to opthalmic and venterinary sales. What was the contribution of Intergel sales in Europe? Are sales still very slow to increase? Was this growth mainly due to a big order from Alcon? Next the Oral division had a sales increase of only 2%. Can anyone explain this low growth quarter for this division? In the past we have seen consistent 15-25% growth from the Oral side. Now I know this past qtr is the slowest for LCBM but just looking for clarification. Thanks in advance. MHat

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next